3PC-039 Centralised non-hazardous intravenous compounding: improvement of clinical practice

BACKGROUND: In April 2016 the Central IntraVenous Additive Service (CIVAS) began to compound non-toxic injectable therapies with a robotic system.(1) The production started with antiemetic therapies, followed by antibiotic therapies ready to infuse, as cefazoline 1 g in syringes and piperacillin-taz...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Eur J Hosp Pharm
Main Authors: Celestino, S, Leoni, S, Guglielmi, S, Moriconi, L, Marinozzi, A, Polidori, C, Paolucci, D, Bufarini, C
Formáid: Artigo
Teanga:Inglês
Foilsithe: BMJ Group 2018
Ábhair:
Section 3: Production and compounding
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535527/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.91
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla